Literature DB >> 32008333

Delivering safe and effective stereotactic body radiation therapy for patients with centrally located early stage non-small cell lung cancer.

Justin M Haseltine1, Andreas Rimner1, Annemarie F Shepherd2, Abraham J Wu1, Daphna Y Gelblum1, Narek Shaverdian1, Daniel R Gomez1, Charles B Simone2.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32008333     DOI： 10.21037/cco.2019.12.17

Source DB:  PubMed          Journal:  Chin Clin Oncol        ISSN： 2304-3865


× No keyword cloud information.
  3 in total

1.  Combination of albumin concentration and neutrophil-to-lymphocyte ratio for predicting overall survival of patients with non-small cell lung cancer.

Authors:  Jinsen Weng; Jieping Huang; Wei Yu; Zhiyong Zhao; Biao Zhu; Jingping Lin; Yibin Cai; Jiulong Zhang; Weikun Su; Xiaohui Chen; Kunshou Zhu; Shaofeng Lin
Journal:  J Thorac Dis       Date:  2021-09       Impact factor: 3.005

2.  EHD2 inhibits the invasive ability of lung adenocarcinoma and improves the prognosis of patients.

Authors:  Sheng Wei; Jingjing Shao; Jinming Wang; Tianye Zhao; Jia Liu; Xiying Shen; Yidan Wang; Haizhen Chen; Gaoren Wang
Journal:  J Thorac Dis       Date:  2022-07       Impact factor: 3.005

3.  The efficacy and safety of Zengxiao Jiandu decoction combined with definitive concurrent chemoradiotherapy for unresectable locally advanced non-small cell lung cancer: a randomized, double-blind, placebo-controlled clinical trial.

Authors:  Leilei Wu; Yaoyao Zhu; Xiaoshuai Yuan; Yu Liu; Qiongya Wu; Qinghua Xu; Min Hu; Jingjing Kang; Jiamei Fu; Xiaomei Gong; Hongyu Wu; Yong Cai; Lixin Wang; Yi Lu; Yan Li; Hui Liu; Yaping Xu
Journal:  Ann Transl Med       Date:  2022-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.